Source: Health Canada shortage reports · Updated Oct 27, 2026
Some Entacapone products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 31, 2027.
A medication used together with levodopa to treat Parkinson's disease.
Products affected
1 / 5
In shortage since
Jul 28, 2026
Est. full return
Jan 31, 2027
Reports on file
27
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
MINT-ENTACAPONE
200MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02535939 · since Jul 28, 2026, est. end Jan 31, 2027 · Disruption of the manufacture of the drug.
Resolved
TEVA-ENTACAPONE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02375559 · ended Jul 31, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Jun 1, 2026 · Delay in shipping of the drug.
Resolved
TEVA-ENTACAPONE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02375559 · ended Apr 15, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended May 26, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
TEVA-ENTACAPONE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02375559 · ended Aug 28, 2024 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Jul 22, 2024 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Dec 19, 2023 · Delay in shipping of the drug.
Resolved
TEVA-ENTACAPONE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02375559 · ended Aug 3, 2023 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Apr 21, 2023 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Oct 19, 2022 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Apr 28, 2022 · Requirements related to complying with good manufacturing practices.
Showing 12 of 27 reports. All reports are on file with Health Canada.
What's happening
Entacapone is currently affected by an active shortage report filed with Health Canada by MINT PHARMACEUTICALS INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Entacapone is classified under “DOPAMINERGIC AGENTS” (ATC N04BX).
Recent changes
Oct 27, 2026
Status changed
Sep 23, 2026
Shortage resolved
Jul 28, 2026
New report filed
Common questions
What is Entacapone used for?
A medication used together with levodopa to treat Parkinson's disease.
When will Entacapone be back in stock in Canada?
The latest manufacturer estimate is Jan 31, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Entacapone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.